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Femoral Vein Transposition Arteriovenous Fistula
is a Feasible Option in “Selected” Patients as
Hemodialysis Access
Zia Ur Rehman, MBBS, FCPS, ChM Vascular and Endovascular Surgery, Asfia Arham, MBBS,
and Ziad Sophie, MD

Introduction: Lower extremity hemodialysis access is offered to the patients who have severe central venous stenosis. Femoral vein transposition arteriovenous fistula (FV
tAVF) is an alternative to lower leg arteriovenous prosthetic
grafts. Its safety and patency is under observation.
Materials and Methods: This is a retrospective review of
patients who had FV tAVF between January 2011 and March
2016. Preoperative clinical findings, intraoperative findings,
postoperative complications, and patency of the AVF were
noted and analyzed.
Results: There were 7 patients who underwent FV tAVF
during this study period. Most patients were female (6 : 1),
with mean age of 45.2 years (range, 33–55 years). All
patients were hypertensive. Mean body mass index was
26.1 kg/m2. Patient had on average previous 6 dialysis accesses. Most patients had preoperative venograms (6/7).
Mean interval between initiation of dialysis and creation of
the arteriovenous fistula was 1.08 years. All procedures were
done under general anesthesia. Four patients required extension of FV with either the small segment of polytetrafluorethylene or vein graft. Two patients had early postoperative
complications. One patient developed hematoma, whereas
other had wound dehiscence. All the accesses were utilized
for dialysis after a mean interval of 6 weeks. All patients had
a patent fistula on average follow-up of 2 years.
Conclusion: Appropriate patient selection for FV tAVF can
provide good patency with low incidence of complications.
Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan
Received: September 28, 2018; Accepted: November 5, 2018
Corresponding author: Zia Ur Rehman, MBBS, FCPS, ChM
Vascular and Endovascular Surgery. Department of Surgery,
Aga Khan University Hospital, Stadium Road, Karachi 74800,
Pakistan
Tel: +92-32-12039951, Fax: +92-21-34932095
E-mail: ziaur.rehman@aku.edu
©2019 The Editorial Committee of Annals of Vascular Diseases. This article is distributed under the terms of the Creative
Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the credit of the original work, a link to
the license, and indication of any change are properly given, and the original work is not used for commercial purposes. Remixed or transformed
contributions must be distributed under the same license as the original.

Annals of Vascular Diseases Vol. 12, No. 1 (2019)

This can be considered for good risk individuals undergoing
their first lower extremity access.
Keywords: lower extremity, arteriovenous access, hemodialysis

Introduction
In patients requiring hemodialysis, the upper limb is the
preferred choice for access creation. Unfortunately, due
to lack of an optimal health care system in Pakistan, most
of the patients for hemodialysis access present late. These
patients have central catheters in place. Their forearm
veins have already been exhausted due to multiple venipunctures or previously failed hemodialysis accesses. They
develop central venous stenosis quite earlier. The lower
limb is the next option for creating a dialysis access in
patients who have bilateral upper arms central stenosis.
Lower leg prosthetic grafts are reported with a higher
incidence of graft and wound infection. Patency is lower
because of the early formation of neointimal hyperplasia
at the graft-venous anastomosis. They are also associated
with higher risk of steal syndrome. One option in the
lower extremity is creation of arteriovenous (AV) access
using the great saphenous vein. This has not shown good
results, likely related to its thick wall and multiple valves
acting as a nidus for neointimal hyperplasia. Reports on
saphenous vein superﬁcialization demonstrated poor results.1)
The femoral vein (FV) is good conduit for creating an
AV access. It has proved useful in a variety of settings
favoring a large venous conduit.2–4) It has a thin wall containing fewer valves compared with the great saphenous
vein. FV has been utilized as an autogenous ﬁstula in
various centers with acceptable results. The primary and
secondary patency for this access has been documented as
91% and 84%5) at one year.
The FV is deep seated and has multiple tributaries. It
requires extensive dissection for harvesting. Patients on
long-term hemodialysis are already nutritionally depleted
25
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and are expected to have higher wound-related issues
compared with the normal population. There are many
studies mentioning increased incidence of steal syndrome
and wound-related complications with this procedure,
raising safety concerns for this procedure.6,7)
The aim of this study was to determine patency rate and
the complications in patients undergoing FV transposition
arteriovenous ﬁstula (FV tAVF) at our institute.

Materials and Methods
This is a retrospective case series. It included patients from
January 2011 to March 2016. All those patients who
underwent FV tAVF were included in this study. Patients
with incomplete follow-up or records were excluded from
the study. The study was approved by the institutional
ethical review committee (3162-Sug-ERC-14). The data of
patients were retrieved from the hospital database using
International Classiﬁcation of Diseases coding system.
Designed proforma was ﬁlled. Data related to patient
demographics, comorbidities, preoperative clinical ﬁndings especially arterial and venous systems of the lower
extremity, intraoperative ﬁndings, and postoperative complications were noted. Patientsʼ ﬁles were also reviewed for
follow-up visits to evaluate patency of access. Complications such as AV access thrombosis, wound dehiscence,
hematoma formation, and leg ischemia were also noted.
At our institute, we prefer upper extremity accesses. Patients are initially evaluated for radiocephalic or brachiocephalic arteriovenous ﬁstulae. These are our ﬁrst choices.
If both options are not available, patients are evaluated
for basilic transposition arteriovenous ﬁstula either in
the forearm or most commonly in the upper arm. If both
basilic veins are not available, patients are considered for
forearm or upper arm prosthetic grafts. Patients are also
considered for axillo-axillary arteriovenous grafts before
offering lower extremity accesses. Our preference in the
lower leg is more for FV tAVF than the prosthetic grafts.
In this case series, those patients were included who
had exhausted upper arm veins and have bilateral upper
arm central venous stenosis. All patients had preoperative
bilateral upper extremity venogram to check for central
venous stenosis. Preoperative venous mapping of lower
extremity veins were also performed in all patients. Patients with the previous history of deep venous thrombosis
were not offered this operation. Same was true if they
had arterial insufﬁciency. Speciﬁc history for intermittent
claudication and detailed peripheral arterial examination was done. Only patients with no history of arterial
insufﬁciency and palpable ankle pulses were offered this
procedure. Preoperative venogram of lower extremity
was also performed to rule out if the patient had a history
of femoral cannulation. This is to rule out iliac venous
26

stenosis. The surgery followed the technique described by
Gradman et al. in 20018) and 2005.9) A longitudinal incision from the inguinal crease to just above the knee was
made to harvest the FV. After division of subcutaneous
tissue, the sartorius muscle was identiﬁed. This was well
mobilized to havest underlying vein. Care was taken to
preserve as many femoral artery branches as possible. Vein
tributaries were double ligated. The vein was dissected
free from its junction to the profunda femoris vein proximally to beyond the adductor hiatus distally. The length
of the vein harvested depended on the size of the patient:
thinner patients required lesser vein than obese patients.
A subcutaneous tunnel was created in the anterolateral
thigh. The vein was later placed in this tunnel. The vein
was transposed superﬁcially and anastomosed to the distal
femoral artery. Tapering of the vein was done in patients
when there was a discrepancy between the diameter of the
FV and the artery. If required, a small segment of the prosthetic graft was used to obtain an appropriate size of the
vein. Same was the approach if the length of the dissected
vein became inadequate for making the anastomosis comfortably. This does happen in patients having relatively
thick subcutaneous tissue. The wounds were closed in two
layers over a suction drain. Patients were closely observed
for immediate postoperative complications especially steal
syndrome, bleeding, graft thrombosis, or venous insufﬁciency. They were kept inpatient and discharged when
fully mobilized and stable. Patients were followed in the
clinic after 1 week to evaluate ﬁstula patency and to detect
wound-related complications. If everything is ﬁne, patients were followed after 5 weeks to check the maturation
of access. If matured, accesses were allowed for cannulation. Patients were followed after every 6 months and then
annually. This is to detect any developing complications
and needling issue.
Data were entered and analyzed using SPSS version 19.
Quantitative variables were reported as mean ± standard
deviation, or median with interquartile ranges, depending
upon the distribution of the data. Qualitative variables
were reported and expressed as proportion and percentage of patients.

Results
Seven patients underwent FV tAVF during this study period. Most of the patients were female (6 : 1). Mean age was
45.2 years (range, 33–55 years). All patients were hypertensive (Table 1). The mean interval between the initiation
of dialysis and creation of the FV tAVF was 1.08 years.
Six patients had venogram to rule out any stenosis in the
iliac veins preoperatively. Particulars related to American
Society of Anesthesiologists type, type of anesthesia and
types of the incision are given in Table 2.
Annals of Vascular Diseases Vol. 12, No. 1 (2019)
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Table 1

Preoperative patient characteristics
Variables

N=7

Average age in years (range)

45.2 (35.0–55.0)

Females

6 (85.0%)

Diabetes mellitus

1 (14.3%)

Hypertension

7 (100%)

Ischemic heart disease

1 (14.3%)

Hypothyroid

1 (14.3%)

Hepatitis C

1 (14.3%)

Infective endocarditis

1 (14.3%)

Tuberculosis

1 (14.3%)

Mean body mass index (kg/m2) (range)

26.4 (25.0–30.0)

Previous history of femoral dialysis catheters

1 (14.3%)

Venograms of lower legs

6 (85.7%)

Mean number of dialysis accesses

6

Two patients developed postoperative complications
(Table 3). One patient developed hematoma and did required exploration to evacuate it. She was on therapeutic
oral anticoagulation, which was stopped before the operation. Perioperatively, there was no active bleeding point
identiﬁed. One patient had wound dehiscence, which
required washout and partial closure of the wound. All
the patent accesses were utilized for dialysis after a mean
interval of 6 weeks. One patient developed central venous
stenosis 6 months later and underwent iliac vein stenting.
All the patent accesses were utilized for dialysis after a
mean interval of 6 weeks. All patients had a patent ﬁstula
on average follow-up of 2 years. Primary patency was
85%, and primary-assisted patency was 100% (Table 4).

Discussion
Table 2

Perioperative details
Variables

N=7

Mean ASA grade

2.85

Type of anesthesia
a. General anesthesia

7 (100%)

Type of incision
a. Standard longitudinal

6 (85.7%)

b. Skip incision

1 (14.3%)

Extension of FV by
a. Prosthetic (PTFE) graft

3 (42.8%)

b. Autologous (GSV) graft

1 (14.3%)

ASA: American Society of Anesthesiologists; FV: femoral vein;
PTFE: polytetraﬂuoroethylene; GSV: great saphenous vein

Table 3

Postoperative complications
Complication

N=7

Hematoma

1

Wound dehiscence

1

Steal syndrome requiring intervention

0

Venous swelling requiring fasciotomy

0

Iliac vein angioplasty/stenting

1

Table 4

Follow-up of patients

Patient
no.

Total follow up
(in years)

Fistula patent
(yes/no)

Any intervention
needed

1

1

Yes

2

3

Yes

3

3

Yes

—

4

2.5

Yes

—

5

2

Yes

—

6

1

Yes

—

7

1

Yes

—

—
Iliac vein angioplasty
Iliac vein stenting
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Patients who have exhausted upper extremity veins or
have developed central venous stenosis require an alternate site for hemodialysis access creation.10) The alternate
choice can be the lower limbs where a graft or an autogenous ﬁstula can be formed. Autogenous access can be
created using either the great saphenous vein (GSV) or
the FV. Prosthetic grafts are inferior as they have a higher
incidence of infection11) and lesser patency compared with
autogenous access. In one series of 45 patients using either
polytetraﬂuoroethylene (PTFE) (n=39) or bovine graft
(n=6), the 2 year primary patency rate was 47% with
an infection rate of 18%.12) Unfortunately, GSV also has
shown poor patency.13,14) This is likely due to its relatively
thick wall and reduced chances of maturation.
In this study, there was 1 patient who had a major
wound dehiscence requiring formal washout and partial
closure of the wound. Fortunately, the anastomosis was
well protected by the overlying sartorius muscle. The patient had a usable ﬁstula after 6 weeks.
To decrease wound-related complications, skip incision
technique is also advocated. In 1 patient in the latter half
of the series, skip incision technique was used instead
of a longitudinal incision. Alcocer et al. showed wound
morbidity can be reduced by using small skin incision
technique. They compared a cohort of 12 patients with
FV tAVF created with standard technique versus 13 patients with FV tAVF created with modiﬁed small incision
technique. By modiﬁed technique, they mean small about
12 cm mid-thigh incision. In the standard technique, 5
patients had wound-related complications, whereas no
patient had a wound-related complication in the modiﬁed
group. Patency was similar in both groups.15)
Another problem is size discrepancy between the FV
which is usually more than 10 mm and the superﬁcial
femoral artery. Creating a wider anastomosis always
places these patients to the risk of steal syndrome. The
27

Rehman ZU, et al.

presence of arterial occlusive disease in the lower extremity also contributes to these patients for developing steal
syndrome. Fortunately, none of our patients developed
severe steal. When FV tAVF was ﬁrst described in 2001,
there was initially a higher incidence of lower extremity
ischemia. This complication was subsequently resolved
by improved technique (tapered FV, distal femoral artery
pressure measurement, and fasciotomy) and improved
patient selection (avoiding surgery in patients with a signiﬁcant occlusive disease).
Preoperatively, all patients had normal arterial supply with palpable ankle pulses. Anastomoses were not
more than 5–6 mm in size. It was made possible by either
tapering the vein end or using a small piece of PTFE as
interposition graft. In order to get an adequate length in 1
patient, a small segment of reversed GSV was used, usually
harvested from the same wound.
Patients were followed for any ﬁstula failure or central
venous stenosis. One patient developed limb swelling. This
was due to progressive iliac vein stenosis. Although she
was initially treated with balloon angioplasty, it recurred,
later treated with self-expanding stent. Although there is
potential for signiﬁcant venous morbidity, Wells et al. have
reported fairly minimal long-term venous morbidity using
sophisticated venous imaging.16) No patient developed
signiﬁcant venous swelling in this study. Sidawy et al. emphasized that venous obstructive complications can range
from mild distal edema to compartment syndrome.17)
These complications can be minimized when harvesting of
the vein is limited to the anatomical segment proximal to
the popliteal vein.
The ﬂow rate in FV tAVF is higher than the upper arm
accesses. There is always a risk that they may develop
signs of heart failure. At the 2 years follow-up, fortunately no patient developed signs or symptoms of heart
failure. Jackson pointed out that ﬂow rates in two of his
reported patients with FV tAVF were substantially higher
(2000 mL/min) than generally observed in upper-arm
grafts, but congestive heart failure did not develop in either patient.18)
Patients with peripheral vascular disease and cardiac
failure are not good candidates for this procedure. One
has to be very careful in selecting patients for FV tAVF.

Conclusion
Although FV tAVF is associated with signiﬁcant woundrelated and ischemic complications, we have found in this
study that careful selection of patients can lead to a favorable outcome. We suggest that FV tAVF be considered in
“selected” patients as an alternative before the lower leg
prosthetic grafts.
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